News

AADCO Imaging, LLC of Georgetown, Texas is pleased to announce that it continues to retain the exclusive right to distribute all Comed/GEMSS products in the United States and Canada. Our Master Distributorship Agreement with Comed/GEMSS,...

Research study tests new drug for prevention of atrial fibrillation in those with heart failure Atrial fibrillation, or AF, is a very prevalent and growing heart rhythm disorder that increases the risk of stroke. AF combined with heart...

Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they don't fully understand how the devices work and what to do when they experience an irregular heartbeat....

Canadian Site Activation for Phase 2B/3 Clinical Trial to Begin in 2014 Gencaro Potentially the First Genetically-Targeted Cardiovascular Treatment ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies...

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the publication of the IN-TIME study results in the medical journal The Lancet.1 The randomized, controlled trial is the first worldwide to demonstrate that...

New System Helps Physicians Deliver Cardiac Resynchronization Therapy Optimally and Efficiently to Heart Failure Patients Medtronic, Inc. announced it has received United States Food and Drug Administration (FDA) approval for the Attain...

AliveCor, Inc. announced that more than one million ECGs have been recorded using the AliveCor® Heart Monitor since the first ECG was recorded in January 2013. This significant and steady data flow reiterates the company's focus on the...

Turbo-Tandem® and Turbo Elite® are indicated to treat peripheral ISR, the only on-label products in the industry EXCITE clinical trial proves safety, efficacy of laser technology; uniquely positions SPNC to set new standard of care while...

European approval of next-generation ablation catheter further strengthens St. Jude Medical’s fast-growing ablation technology portfolio St. Jude Medical, Inc., a global medical device company, announced CE Mark approval and first use of the...

Patients Receive New BIOTRONIK Cardiac Resynchronization Therapy Implantable Defibrillators that Grant MRI Access and Reduce Shocks BERLIN, Germany, July 15, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology,...